Xu K - Search Results

1

DEPDC1B is a tumor promotor in development of bladder cancer through targeting SHC1.

Lai CH, Xu K, Zhou J, Wang M, Zhang W, Liu X, Xiong J, Wang T, Wang Q, Wang H, Xu T, Hu H. Lai CH, et al. Among authors: xu k, xu t. Cell Death Dis. 2020 Nov 17;11(11):986. doi: 10.1038/s41419-020-03190-6. Cell Death Dis. 2020. PMID: 33203836 Free PMC article.

2

[Inhibitory effect of doxazosin on the growth of transplanted tumor of prostate cancer cell PC-3 in nude mice].

Guo CY, Wang XF, Xu KX, Dong JQ, Huang XB, Liu SJ, Xu T, Ye HY. Guo CY, et al. Beijing Da Xue Xue Bao Yi Xue Ban. 2005 Jun 18;37(3):273-7. Beijing Da Xue Xue Bao Yi Xue Ban. 2005. PMID: 15968318 Free article. Chinese.

3

The role of Id-1 in chemosensitivity and epirubicin-induced apoptosis in bladder cancer cells.

Hu H, Han HY, Wang YL, Zhang XP, Chua CW, Wong YC, Wang XF, Ling MT, Xu KX. Hu H, et al. Oncol Rep. 2009 Apr;21(4):1053-9. doi: 10.3892/or_00000323. Oncol Rep. 2009. PMID: 19288008

4

Identification of a novel function of Id-1 in mediating the anticancer responses of SAMC, a water-soluble garlic derivative, in human bladder cancer cells.

Hu H, Zhang XP, Wang YL, Chua CW, Luk SU, Wong YC, Ling MT, Wang XF, Xu KX. Hu H, et al. Mol Med Rep. 2011 Jan-Feb;4(1):9-16. doi: 10.3892/mmr.2010.380. Epub 2010 Oct 11. Mol Med Rep. 2011. PMID: 21461556

5

Prevalence, risk factors, and impact on health related quality of life of overactive bladder in China.

Wang Y, Xu K, Hu H, Zhang X, Wang X, Na Y, Kang X. Wang Y, et al. Among authors: xu k. Neurourol Urodyn. 2011 Nov;30(8):1448-55. doi: 10.1002/nau.21072. Epub 2011 Aug 8. Neurourol Urodyn. 2011. PMID: 21826714

6

A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer.

Hu H, Wang YL, Wang GW, Wong YC, Wang XF, Wang Y, Xu KX. Hu H, et al. Urol Oncol. 2013 Oct;31(7):1242-53. doi: 10.1016/j.urolonc.2011.12.003. Epub 2012 Jan 5. Urol Oncol. 2013. PMID: 22226665

7

[Short-term outcome of transobturator sling suspension system AdVance in the treatment of men with moderate to severe stress urinary incontinence].

Xu KX, Zhang XP, Wang D, Hu H, Huang XB, Wang XF. Xu KX, et al. Beijing Da Xue Xue Bao Yi Xue Ban. 2012 Aug 18;44(4):555-7. Beijing Da Xue Xue Bao Yi Xue Ban. 2012. PMID: 22898845 Free article. Chinese.

8

Efficacy and safety of bipolar plasma vaporization of the prostate with "button-type" electrode compared with transurethral resection of prostate for benign prostatic hyperplasia.

Zhang SY, Hu H, Zhang XP, Wang D, Xu KX, Na YQ, Huang XB, Wang XF. Zhang SY, et al. Chin Med J (Engl). 2012 Nov;125(21):3811-4. Chin Med J (Engl). 2012. PMID: 23106879 Clinical Trial.

9

[Expressions of CMTM8 and E-cadherin in primary and metastatic clear cell renal cell carcinoma].

Hu H, Chen JW, Xu KX, Wang D, Wang Y, Wang GW, Zhang SY, Wang XF. Hu H, et al. Beijing Da Xue Xue Bao Yi Xue Ban. 2013 Aug 18;45(4):537-41. Beijing Da Xue Xue Bao Yi Xue Ban. 2013. PMID: 23939157 Free article. Chinese.

10

[Expression of brainderived neurotrophic factor in urine of patients with benign prostatic hyperplasia complicated overactive bladder symptoms].

Hu H, Xu KX, Zhang XP, Fang ZW, Chen JW, Huo F, Wang D, Wang XF. Hu H, et al. Beijing Da Xue Xue Bao Yi Xue Ban. 2014 Aug 18;46(4):519-23. Beijing Da Xue Xue Bao Yi Xue Ban. 2014. PMID: 25131461 Free article. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,602 results

Search Page

Filters